Humacyte News

Analysts' Top Healthcare Picks: Humacyte (HUMA), Janux Therapeutics Inc (JANX)

TipRanksApr 10 21:10 ET

Oppenheimer Keeps Their Buy Rating on Humacyte (HUMA)

TipRanksApr 8 08:25 ET

Humacyte Analyst Ratings

BenzingaApr 1 08:27 ET

Piper Sandler Sticks to Its Hold Rating for Humacyte (HUMA)

TipRanksMar 26 07:06 ET

Humacyte Analyst Ratings

BenzingaMar 25 10:45 ET

Humacyte's Strong Outlook: Buy Rating Affirmed Amid Advancements and Market Opportunity

TipRanksMar 23 10:35 ET

Buy Rating for Humacyte: Anticipated FDA Approval and Strong Financials Signal Growth Potential

TipRanksMar 22 13:35 ET

Humacyte Analyst Ratings

BenzingaMar 8 08:31 ET

Piper Sandler Reaffirms Their Hold Rating on Humacyte (HUMA)

TipRanksMar 8 07:48 ET

Analysts Offer Insights on Healthcare Companies: Embecta Corporation (EMBC), Mettler-Toledo (MTD) and Humacyte (HUMA)

TipRanksFeb 11 12:01 ET

Buy Rating Justified by FDA Review and Commercial Prospects for Humacyte's HAV Device

TipRanksFeb 9 13:25 ET

Humacyte (HUMA) Gets a Buy From BTIG

TipRanksJan 2 09:22 ET

Benchmark Maintains Buy on Humacyte, Lowers Price Target to $15

BenzingaDec 27, 2023 14:23 ET

Humacyte Analyst Ratings

BenzingaDec 27, 2023 14:22 ET

Benchmark Co. Sticks to Their Buy Rating for Humacyte (HUMA)

TipRanksDec 27, 2023 07:35 ET

Humacyte Analyst Ratings

BenzingaDec 11, 2023 06:20 ET

Promising Clinical Trials and Innovative Technology Bolster Buy Rating for Humacyte Stock

TipRanksNov 17, 2023 12:25 ET

Piper Sandler Maintains Neutral on Humacyte, Lowers Price Target to $3-Report Released on 9th Nov 2023

BenzingaNov 10, 2023 17:16 ET

Humacyte Analyst Ratings

BenzingaNov 10, 2023 17:14 ET

Buy Rating and Promising Future Prospects for Humacyte: An Analysis

TipRanksNov 10, 2023 10:25 ET